Physician profile
Maria S Swetech
NPI 1578002408
$2,532.10
in general payments reported to CMS, 2019-2025
23 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,013 · 2020: $101 · 2022: $133 · 2023: $212 · 2024: $587 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,285.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $478.59 | 2019-2025 | Airsupra, Farxiga |
| Amgen INC. | $334.48 | 2019 | |
| Medtronic, INC. | $334.23 | 2023-2024 | Venaseal, Linq II |
| Abbvie INC. | $151.20 | 2019-2025 | |
| Heartflow, INC. | $132.51 | 2022 | |
| Pfizer INC. | $121.35 | 2019 | |
| Sanofi-Aventis U.S. LLC | $120.96 | 2019 | |
| Glaxosmithkline, LLC. | $105.57 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.81 | 2024 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $101.46 | 2020 | |
| Csl Behring | $99.47 | 2019 | |
| Biotronik INC. | $94.61 | 2024 | Biomonitor, Renamic Neo |
| Globus Medical, INC. | $73.30 | 2025 | Senza |
| Bsn Medical INC | $72.38 | 2025 | |
| Hologic Sales and Service, LLC | $38.33 | 2025 | Aptima, Thinprep 2000 Processor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $37.04 | 2025 | Inspire |
| Cipher Pharmaceuticals US LLC | $22.42 | 2025 | Spinosad, Natroba |
| Phathom Pharmaceuticals, INC. | $21.52 | 2024 | Voquezna |
| Saluda Medical Americas, INC. | $20.58 | 2025 | Evoke |
| Merck Sharp & Dohme LLC | $18.25 | 2019 | |
| Intra-Sana Laboratories | $18.03 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.71 | 2025 | Xifaxan |
| Lilly USA, LLC | $16.30 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Swetech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.